CSIMarket
 
Pyxis Oncology Inc   (NASDAQ: PYXS)
 

Pyxis Oncology Inc's Customers Performance

PYXS



 
PYXS's Source of Revenues

List of PYXS Customers




for the same period Pyxis Oncology Inc

List of PYXS Customers





Pyxis Oncology Inc's Comment on Sales, Marketing and Customers





  News about Pyxis Oncology Inc Contracts

Pyxis Oncology Blazes New Trails in Cancer Treatment with PYX-201 and KEYTRUDA Combination Trial,

Pyxis Oncology Initiates Promising New Trial for PYX-201, Expanding Potential in Solid Tumor TreatmentsIn a significant advancement in the field of oncology, Pyxis Oncology Inc. has announced the initiation of a Phase 1/2 clinical trial that explores the combination of PYX-201, an innovative extracellular antibody-drug conjugate (ADC) targeting Extradomain-B Fibronectin (EDB+FN), with Merck s renowned immunotherapy agent KEYTRUDA (pembrolizumab). This trial marks a crucial step toward optimizing treatment protocols for patients suffering from various solid tumors, a category that includes some of the most challenging cancers to treat effectively. Overview of the Combination TrialThe newly launched trial exa...












PYXS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Pyxis Oncology Inc 215.01 0.00 -81.74 56
SUBTOTAL 0.00 0.00 0.00 -

Sources: Pyxis Oncology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pyxis Oncology Inc’s corporate clients.
For your research, we’ve provided 9 tables on Pyxis Oncology Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.